High-purity Enocitabine API — GMP Certified
Enocitabine (BHAC) is a long-chain fatty acid derivative of cytarabine (ara-C) used as an antineoplastic agent for the treatment of acute leukaemia. It acts as a prodrug of cytarabine with improved lipophilicity and CNS penetration. Mediocon Inc manufactures Enocitabine API to IP/BP/EP/USP standards in its GMP-certified facility in Aurangabad, Maharashtra, India.
Our Enocitabine API is supplied to haematological oncology pharmaceutical manufacturers and research institutions globally with comprehensive quality documentation and regulatory support.
Key Features
Applications
Why Choose Mediocon
| Parameter | Specification |
|---|---|
| Assay | NLT 98.0% |
| Loss on Drying | NMT 0.5% |
| Heavy Metals | NMT 20 ppm |
| Residue on Ignition | NMT 0.1% |
| Microbial Limits | Complies with pharmacopoeia |
| Identification | IR, HPLC Compliant |
| Packing | 25 kg HDPE drums / as per requirement |
Mediocon Inc is a GMP-certified API manufacturer and bulk pharmaceutical ingredient supplier based in Aurangabad, Maharashtra, India. We specialise in supplying Enocitabine (CAS 55726-47-1) and over 1,000 other Active Pharmaceutical Ingredients, excipients, herbal extracts, and nutraceutical ingredients to pharmaceutical manufacturers worldwide.
Our Enocitabine is manufactured under strict quality management protocols compliant with WHO-GMP, ISO 9001:2015, and major pharmacopoeial standards (IP, BP, USP, EP). Every batch undergoes full analytical testing — identity (IR/HPLC), assay, related substances, residual solvents (ICH Q3C), heavy metals, and microbial limits — before release with a Certificate of Analysis.
Export Markets
Quality & Compliance